β4 Integrin Amplifies ErbB2 Signaling to Promote Mammary Tumorigenesis
Top Cited Papers
- 1 August 2006
- Vol. 126 (3), 489-502
- https://doi.org/10.1016/j.cell.2006.05.047
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic targetNature Medicine, 2005
- Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesisJournal of Clinical Investigation, 2004
- Epithelial polarity and proliferation control: links from the Drosophila neoplastic tumor suppressorsGenes & Development, 2004
- Cell adhesion and signalling by cadherins and Ig-CAMs in cancerNature Reviews Cancer, 2004
- Tissue architecture: the ultimate regulator of breast epithelial functionCurrent Opinion in Cell Biology, 2003
- The Role of Apoptosis in Creating and Maintaining Luminal Space within Normal and Oncogene-Expressing Mammary AciniCell, 2002
- Grb2 and Shc Adapter Proteins Play Distinct Roles in Neu (ErbB-2)-Induced Mammary Tumorigenesis: Implications for Human Breast CancerMolecular and Cellular Biology, 2001
- Oncogenic transformation by ras and fos is mediated by c-Jun N-terminal phosphorylationOncogene, 2000
- Activation of p53 Function in Carcinoma Cells by the α6β4 IntegrinJournal of Biological Chemistry, 1999
- STAT3β, a Splice Variant of Transcription Factor STAT3, Is a Dominant Negative Regulator of TranscriptionJournal of Biological Chemistry, 1996